Herbal product regulatory dossiers and required documentation MCQs With Answer

Introduction:

This quiz collection on Herbal product regulatory dossiers and required documentation is designed for M.Pharm students preparing for the Regulatory Aspects of Herbal and Biologicals course (MRA202T). It focuses on practical dossier requirements, quality and safety documentation, regulatory formats like CTD/eCTD, stability and analytical data, and region-specific expectations for herbal products. Each question highlights critical documentation elements — botanical identification, GMP, monographs, toxicology, clinical evidence and labeling — enabling learners to understand both the science and regulatory rationale behind dossier compilation. Use these MCQs to test knowledge, identify gaps, and reinforce best practices in preparing compliant herbal product submissions.

Q1. Which CTD/eCTD module primarily contains detailed pharmaceutical quality information such as raw material specifications, manufacturing process, and stability data?

• Module 1 — Administrative and prescribing information
• Module 2 — Quality overall summaries
• Module 3 — Quality (pharmaceutical, biological) documentation
• Module 5 — Clinical study reports

Correct Answer: Module 3 — Quality (pharmaceutical, biological) documentation

Q2. Which document is essential to prove correct botanical identity of a raw herbal material in a regulatory dossier?

• Certificate of Analysis (CoA) only
• Voucher specimen with botanical authentication
• Manufacturing batch record
• Sales invoice from supplier

Correct Answer: Voucher specimen with botanical authentication

Q3. For herbal products, which analytical approach is most appropriate to demonstrate batch-to-batch consistency of complex extracts?

• Single marker assay only
• Chromatographic fingerprint profile combined with marker assays
• Microbial culture testing alone
• Physical appearance inspection only

Correct Answer: Chromatographic fingerprint profile combined with marker assays

Q4. Which stability guideline is commonly referenced for establishing shelf-life of herbal medicines intended for ICH regions?

• ICH Q1A (R2) — Stability Testing of New Drug Substances and Products
• ICH Q6A — Specifications: Test Procedures and Acceptance Criteria
• ICH Q4B — Pharmacopoeial Discussion
• ICH Q9 — Quality Risk Management

Correct Answer: ICH Q1A (R2) — Stability Testing of New Drug Substances and Products

Q5. Which dossier component documents adherence to Good Manufacturing Practices (GMP) for a herbal product manufacturer?

• Quality target product profile (QTPP)
• Current Good Manufacturing Practice (cGMP) certificate or inspection report
• Clinical study protocols
• Pharmacopoeial monograph citation

Correct Answer: Current Good Manufacturing Practice (cGMP) certificate or inspection report

Q6. When presenting safety data for a traditional herbal product with long history of use but limited toxicology, which regulatory approach is commonly acceptable?

• Omit safety information entirely
• Submit a well-documented bibliographic/traditional use safety dossier plus any available toxicology
• Only submit clinical efficacy trials
• Submit an animal toxicity study identical to synthetic drug requirements

Correct Answer: Submit a well-documented bibliographic/traditional use safety dossier plus any available toxicology

Q7. Which contaminant test is particularly critical for herbal materials sourced from agricultural origins and must be documented in the dossier?

• Nitrosamine levels
• Pesticide residues and heavy metals
• Radioactivity screening only
• Endotoxin levels only

Correct Answer: Pesticide residues and heavy metals

Q8. In an herbal dossier, what is the purpose of a Certificate of Analysis (CoA) provided by the raw material supplier?

• To describe clinical outcomes of the product
• To certify analytical test results for specific batches of material
• To replace stability testing requirements
• To provide marketing claims and labeling text

Correct Answer: To certify analytical test results for specific batches of material

Q9. Which module of the CTD contains clinical pharmacology and clinical study reports for a herbal medicinal product?

• Module 1
• Module 3
• Module 4
• Module 5

Correct Answer: Module 5

Q10. For herbal extracts, what documentation is most important to justify specification limits for active markers or fingerprints?

• Random supplier testimonials
• Justification based on manufacturing capability only
• Scientific justification using batch data, pharmacopoeial ranges, and relevance to activity/safety
• Label claims without supporting data

Correct Answer: Scientific justification using batch data, pharmacopoeial ranges, and relevance to activity/safety

Q11. Which regulatory document specifically addresses permissible microbial limits for herbal products and sets test methods?

• Pharmacopoeial monographs (e.g., IP, USP, BP) and microbial limits chapters
• Clinical trial investigator brochure
• Marketing authorization letter
• Patent application

Correct Answer: Pharmacopoeial monographs (e.g., IP, USP, BP) and microbial limits chapters

Q12. What is a Herbal Drug Master File (HDMF) used for in regulatory submissions?

• To replace the need for clinical studies
• To provide confidential detailed information on raw material or extract to a regulator without disclosing it to the applicant
• To apply for patent protection of a herbal formulation
• To document marketing strategies

Correct Answer: To provide confidential detailed information on raw material or extract to a regulator without disclosing it to the applicant

Q13. Which dossier element demonstrates control of variability introduced by seasonal or geographical differences in herbal raw materials?

• Batch manufacturing records for a single batch
• Supplier qualification, specification ranges, and multi-batch analytical data
• Only the finished product label
• Clinical reports only

Correct Answer: Supplier qualification, specification ranges, and multi-batch analytical data

Q14. For herbal products containing volatile solvents during extraction, which documentation is required in the quality dossier?

• Residual solvent testing and justification following ICH Q3C
• Only visual inspection of odor
• No documentation is necessary for traditional products
• Only microbial limit test results

Correct Answer: Residual solvent testing and justification following ICH Q3C

Q15. Which type of clinical evidence is generally required when a herbal product makes specific therapeutic claims beyond traditional indications?

• Bibliographic traditional use evidence alone
• Well-controlled clinical trials demonstrating efficacy and safety
• Only in vitro pharmacology reports
• No evidence is required if the product is natural

Correct Answer: Well-controlled clinical trials demonstrating efficacy and safety

Q16. In an eCTD submission, what is the significance of a content type index and hyperlinked documents?

• They are optional decorative elements
• They ensure navigability, regulatory compliance and automated lifecycle management of dossier documents
• They replace the need for signatures
• They are only used for internal company archives

Correct Answer: They ensure navigability, regulatory compliance and automated lifecycle management of dossier documents

Q17. Which label statement is typically NOT acceptable on a registered herbal medicinal product without appropriate evidence?

• “Traditionally used for relief of mild digestive discomfort”
• “Clinically proven to cure cancer”
• “Store below 30°C”
• “Keep out of reach of children”

Correct Answer: “Clinically proven to cure cancer”

Q18. What documentation should a dossier include to demonstrate control of heavy metal contamination in herbal raw materials?

• Heavy metal test results (e.g., Pb, Cd, Hg, As) and supplier controls
• Only a supplier statement without testing
• Clinical adverse event reports only
• Only manufacturing process description

Correct Answer: Heavy metal test results (e.g., Pb, Cd, Hg, As) and supplier controls

Q19. Which regulatory body or guidance is specifically relevant in India for traditional herbal system approvals?

• U.S. FDA OTC monographs only
• AYUSH guidelines and the Ministry of AYUSH regulatory frameworks
• European Medicines Agency herbal directive only
• Codex Alimentarius for food additives only

Correct Answer: AYUSH guidelines and the Ministry of AYUSH regulatory frameworks

Q20. What is the primary purpose of a pharmacovigilance plan in the dossier of a herbal medicinal product?

• To provide marketing strategies for sales growth
• To outline how safety will be monitored, adverse events collected and risks managed post-authorisation
• To replace quality control testing
• To list manufacturing equipment suppliers

Correct Answer: To outline how safety will be monitored, adverse events collected and risks managed post-authorisation

Download